Trials / Completed
CompletedNCT03054064
Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Parker Hannifin Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of the Indego exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular Accident (CVA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Indego Exoskeleton | Six study sessions including five Indego training sessions over two weeks. |
Timeline
- Start date
- 2017-02-21
- Primary completion
- 2017-12-28
- Completion
- 2018-01-17
- First posted
- 2017-02-15
- Last updated
- 2020-04-07
- Results posted
- 2020-04-07
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03054064. Inclusion in this directory is not an endorsement.